Moving towards oral delivery of biologics
European Pharmaceutical Review
FEBRUARY 22, 2023
1 Used to treat a range of chronic diseases (eg, diabetes, rheumatoid arthritis, psoriasis, Crohn’s disease, haemophilia, etc), it is projected that the sales of biologics will rise from $380 billion in 2022 to $416 billion in 2023, and to almost $600 billion in 2027. We have confirmed this in close to 100 subjects who have swallowed the RP.”
Let's personalize your content